Results 151 to 160 of about 30,590 (168)
Some of the next articles are maybe not open access.

Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry disease

Molecular Genetics and Metabolism, 2017
Robert J. Desnick   +2 more
exaly  

Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells

Microbial Pathogenesis, 2008
Kinnosuke Yahiro   +2 more
exaly  

Globotriaosylceramide (Gb3) contributes to LoVo/Dx chemoresistance

2023
openaire   +1 more source

Testing Gb3(CD77) Expression Level in Cancer Cells

Proceedings of the 2nd Conference on Artificial Intelligence and Healthcare, 2021
openaire   +1 more source

URINARY TRIAOSYLCERAMIDE (GB3) AS A MARKER OF CARDIAC DISEASE

2011
SCHIFFMANN RAPHAEL   +3 more
openaire   +5 more sources

Tandem Mass Spectrometry Quantitation of Lyso-Gb3 and Six Related Analogs in Plasma for Fabry Disease Patients

Current Protocols in Human Genetics, 2016
Michel Boutin   +2 more
exaly  

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

Genetics in Medicine, 2019
Satoshi Ishii   +2 more
exaly  

Fabry Disease Biomarkers: Analysis of Urinary Lyso-Gb3 and Seven Related Analogs Using Tandem Mass Spectrometry

Current Protocols in Human Genetics, 2016
Michel Boutin   +2 more
exaly  

One-step synthesis of carbon-13-labeled globotriaosylsphingosine (lyso-Gb3), an internal standard for biomarker analysis of Fabry disease

Molecular Genetics and Metabolism, 2018
Michael H. Gelb, Xinying Hong
exaly  

Plasma lyso-Gb3 as a diagnostic marker for Fabry disease

Molecular Genetics and Metabolism, 2018
Sarah Young   +9 more
openaire   +1 more source
fabry disease
medicine
globotriaosylceramide
globotriaosylsphingosine
glycosphingolipids
globotriaosylceramide gb3
lipid raft
glycosphingolipid
shiga toxin
previous   14  15  16  17  

Home - About - Disclaimer - Privacy